BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3002464)

  • 1. Large-scale purification of alpha 2-adrenergic receptor-enriched membranes from human platelets. Persistent association of guanine nucleotides with nonpurified membranes.
    Neubig RR; Szamraj O
    Biochim Biophys Acta; 1986 Jan; 854(1):67-76. PubMed ID: 3002464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for receptor-regulated phosphotransfer reactions involved in activation of the adenylate cyclase inhibitory G protein in human platelet membranes.
    Jakobs KH; Wieland T
    Eur J Biochem; 1989 Jul; 183(1):115-21. PubMed ID: 2502397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of fluoride on adenylate cyclase activity and guanine nucleotide regulation of agonist high-affinity receptor binding.
    Stadel JM; Crooke ST
    Biochem J; 1988 Aug; 254(1):15-20. PubMed ID: 2845943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]-p-aminoclonidine to alpha 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes.
    Piletz JE; Andorn AC; Unnerstall JR; Halaris A
    Biochem Pharmacol; 1991 Jul; 42(3):569-84. PubMed ID: 1677571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
    Gerhardt MA; Wade SM; Neubig RR
    Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of coupling system of receptor-adenylate cyclase induced by epinephrine and GTP in plasma membranes of rat liver.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1978 Nov; 544(1):113-27. PubMed ID: 214146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 3H-para-aminoclonidine binding to different platelet preparations.
    Piletz JE; Halaris A
    J Neural Transm Gen Sect; 1990; 82(1):11-29. PubMed ID: 1976318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of catecholamine-stimulated [3H]GDP release in adipocyte membranes from exercise-trained rats.
    Izawa T; Komabayashi T; Tsuboi M; Koshimizu E; Suda K
    Jpn J Physiol; 1986; 36(5):1039-45. PubMed ID: 3031346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3H-clonidine and 3H-p-aminoclonidine interactions in vitro with central and peripheral alpha 2-adrenergic receptors.
    U'Prichard DC
    Prog Clin Biol Res; 1981; 71():53-74. PubMed ID: 6276902
    [No Abstract]   [Full Text] [Related]  

  • 11. Clonidine p-isothiocyanate, an affinity label for alpha 2-adrenergic receptors on human platelets.
    Atlas D; Steer ML
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1378-82. PubMed ID: 6280179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-p-Fluorosulfonylbenzoyl guanosine as a probe for the GTP-binding protein in alpha 2-adrenergic receptor-adenylate cyclase systems.
    Limbird LE; Buhrow SA; Speck JL; Staros JV
    J Biol Chem; 1983 Sep; 258(17):10289-93. PubMed ID: 6309799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
    Mukherjee A
    Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a beta-adrenergic receptor in porcine trachealis muscle.
    Popovich KJ; Hiller C; Hough A; Norris JS; Cornett LE
    Am J Physiol; 1984 Nov; 247(5 Pt 1):C342-9. PubMed ID: 6093567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelet adenylate cyclase: persistent binding of guanine nucleotide is central to the regulation of both hormone-stimulated and basal activities.
    Olson CV; Smiley PA; Lad PM
    Biochim Biophys Acta; 1985 Jun; 845(3):411-20. PubMed ID: 3924118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
    Turner JT; Ray-Prenger C; Bylund DB
    Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
    McKernan RM; Howard MJ; Motulsky HJ; Insel PA
    Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy in the regulatory effects of sodium and guanine nucleotides on adrenaline and clonidine binding to alpha 2-adrenoceptors in human fat cell membranes.
    Gonzalez JL; Carpene C; Berlan M; LaFontan M
    Eur J Pharmacol; 1981 Dec; 76(2-3):289-93. PubMed ID: 6277648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical assessment of the platelet adenylate cyclase system as a potential model for testing alpha 2 adrenergic activity.
    Ferry N; Henry D; Battais E; Mary A; Bonne C; Hanoune J
    Biochem Pharmacol; 1986 May; 35(9):1511-6. PubMed ID: 2871841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.